These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 745027)

  • 1. The use of the carbon replica technique to investigate the surface of pharmaceutical powders by transmission electron microscopy.
    Ludwig A; Jacob W; Van Ooteghem M
    J Pharm Belg; 1978; 33(5):292-6. PubMed ID: 745027
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of powder produced by evaporative precipitation into aqueous solution (EPAS) and spray freezing into liquid (SFL) technologies using novel Z-contrast STEM and complimentary techniques.
    Vaughn JM; Gao X; Yacaman MJ; Johnston KP; Williams RO
    Eur J Pharm Biopharm; 2005 May; 60(1):81-9. PubMed ID: 15848060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spray-dried microparticles containing polymeric nanocapsules: formulation aspects, liquid phase interactions and particles characteristics.
    Tewa-Tagne P; Briançon S; Fessi H
    Int J Pharm; 2006 Nov; 325(1-2):63-74. PubMed ID: 16872767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on particle size problems. IX. Specific surface area as a measure in pharmacopoeial tests of powders in the sub-sieve range.
    Moller N
    Dan Tidsskr Farm; 1972; 46(2):47-60. PubMed ID: 5041573
    [No Abstract]   [Full Text] [Related]  

  • 5. The influence of formulation components on the aerosolisation properties of spray-dried powders.
    Rabbani NR; Seville PC
    J Control Release; 2005 Dec; 110(1):130-40. PubMed ID: 16226334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid-phase exfoliation of graphite towards solubilized graphenes.
    Bourlinos AB; Georgakilas V; Zboril R; Steriotis TA; Stubos AK
    Small; 2009 Aug; 5(16):1841-5. PubMed ID: 19408256
    [No Abstract]   [Full Text] [Related]  

  • 7. Improving flow properties of ibuprofen by fluidized bed particle thin-coating.
    Ehlers H; Räikkönen H; Antikainen O; Heinämäki J; Yliruusi J
    Int J Pharm; 2009 Feb; 368(1-2):165-70. PubMed ID: 19010403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Electron microscopic studies of powders].
    Borzunov EE; Vasilenko VP; Kruglitskiĭ MM
    Farm Zh; 1971; 26(6):67-8. PubMed ID: 5163064
    [No Abstract]   [Full Text] [Related]  

  • 9. Elastic modulus measurements from individual lactose particles using atomic force microscopy.
    Perkins M; Ebbens SJ; Hayes S; Roberts CJ; Madden CE; Luk SY; Patel N
    Int J Pharm; 2007 Mar; 332(1-2):168-75. PubMed ID: 17074456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel ultra-rapid freezing particle engineering process for enhancement of dissolution rates of poorly water-soluble drugs.
    Overhoff KA; Engstrom JD; Chen B; Scherzer BD; Milner TE; Johnston KP; Williams RO
    Eur J Pharm Biopharm; 2007 Jan; 65(1):57-67. PubMed ID: 16987642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasonic de-agglomeration of barium titanate powder.
    Marković S; Mitrić M; Starcević G; Uskoković D
    Ultrason Sonochem; 2008 Jan; 15(1):16-20. PubMed ID: 17845864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aerosolization properties, surface composition and physical state of spray-dried protein powders.
    Bosquillon C; Rouxhet PG; Ahimou F; Simon D; Culot C; Préat V; Vanbever R
    J Control Release; 2004 Oct; 99(3):357-67. PubMed ID: 15451594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical characteristics and aerosolization performance of insulin dry powders for inhalation prepared by a spray drying method.
    You Y; Zhao M; Liu G; Tang X
    J Pharm Pharmacol; 2007 Jul; 59(7):927-34. PubMed ID: 17637186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimisation of powders for pulmonary delivery using supercritical fluid technology.
    Rehman M; Shekunov BY; York P; Lechuga-Ballesteros D; Miller DP; Tan T; Colthorpe P
    Eur J Pharm Sci; 2004 May; 22(1):1-17. PubMed ID: 15113578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients.
    Minne A; Boireau H; Horta MJ; Vanbever R
    Eur J Pharm Biopharm; 2008 Nov; 70(3):839-44. PubMed ID: 18620052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confocal Raman microscopy to probe content uniformity of a lipid based powder for inhalation: a quality by design approach.
    Schoenherr C; Haefele T; Paulus K; Francese G
    Eur J Pharm Sci; 2009 Aug; 38(1):47-54. PubMed ID: 19501161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerosolization behavior of carrier-free L-leucine coated salbutamol sulphate powders.
    Raula J; Lähde A; Kauppinen EI
    Int J Pharm; 2009 Jan; 365(1-2):18-25. PubMed ID: 18789380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microemulsion-mediated hydrothermal synthesis of photocatalytic TiO2 powders.
    Lu CH; Wu WH; Kale RB
    J Hazard Mater; 2008 Jun; 154(1-3):649-54. PubMed ID: 18077085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards screening of inhalation formulations: measuring interactions with atomic force microscopy.
    Bunker M; Davies M; Roberts C
    Expert Opin Drug Deliv; 2005 Jul; 2(4):613-24. PubMed ID: 16296789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quil A-lipid powder formulations releasing ISCOMs and related colloidal structures upon hydration.
    Demana PH; Davies NM; Hook S; Rades T
    J Control Release; 2005 Mar; 103(1):45-59. PubMed ID: 15710499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.